Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and signaling fullness to your brain, making it easier to eat less without feeling deprived. Clinical trials show that patients on semaglutide lose approximately 15 percent of their body weight over 68 weeks, though individual timelines vary based on starting weight, metabolism, and adherence to treatment.

What Happens During Your First Week of Semaglutide

The first seven days of semaglutide treatment often bring subtle but noticeable changes in appetite and food cravings. Many patients report that foods they once enjoyed—especially high-fat or sugary items—become less appealing, and portion sizes naturally decrease without conscious effort. This appetite suppression happens because semaglutide activates GLP-1 receptors in your brain's satiety centers, creating a biological shift rather than requiring willpower alone.

Nausea and mild digestive changes occur in some patients during week one, typically resolving within a few days as your body adjusts. Starting with the lowest effective dose minimizes these early side effects while still producing appetite reduction. PlexusDx's compounded semaglutide allows flexible dosing adjustments, ensuring you begin at a level your body tolerates well.

Expected Weight Loss Results by Month

Weeks two through four mark the onset of visible weight loss for most patients, with average drops of one to two pounds per week during this initial phase. This early progress reflects both reduced calorie intake from decreased appetite and your body's metabolic response to semaglutide. By the end of month one, many patients report four to eight pounds lost, though results depend on baseline weight and diet consistency.

Months two through three typically show continued steady loss of one to two pounds weekly, with cumulative weight loss reaching ten to twenty pounds. As your dose stabilizes, your body adapts to the medication's appetite-suppressing effects, and weight loss momentum often plateaus slightly before resuming as you potentially increase your dose. PlexusDx patients can adjust their dose on their schedule without facing price changes, supporting consistent progress over time.

By month four through six, many patients reach a rhythm of losing one to one-and-a-half pounds per week, with total weight loss approaching twenty to thirty pounds from baseline. Longer-term studies show that patients who maintain semaglutide treatment continue losing weight through month twelve and beyond, with some reaching thirty to fifty pounds total loss depending on individual factors.

Factors That Speed Up or Slow Down Your Weight Loss

Your genetics play a significant role in how quickly you respond to semaglutide, particularly variations in the GLP1R and GIPR genes that regulate appetite signaling. PlexusDx's Precision Peptide Genetic Test identifies your genetic predispositions across 14 metabolic pathways and 150+ insights, helping predict your likely response pattern and optimize your treatment from the start. Patients with certain genetic profiles experience faster initial weight loss and better long-term outcomes when matched with personalized dosing strategies.

Diet quality, physical activity, sleep duration, and stress management directly impact your rate of weight loss on semaglutide. While semaglutide dramatically reduces hunger, eating nutrient-dense foods and moving your body amplifies results compared to medication alone. Inconsistent medication adherence, frequent high-calorie meals despite reduced appetite, and poor sleep quality can slow progress by ten to thirty percent compared to patients optimizing these lifestyle factors.

Realistic Long-Term Weight Loss Expectations on Semaglutide

Most patients using semaglutide continuously lose weight for twelve to twenty months before reaching a plateau, at which point weight stabilizes rather than increases. This plateau reflects your new metabolic set point and appetite baseline at that lower body weight. Research shows that stopping semaglutide often leads to gradual weight regain, while maintaining treatment sustains losses long-term.

Total weight loss by one year averages fifteen to twenty-five percent of starting body weight in clinical populations, though some patients exceed thirty percent loss depending on their genetic response and lifestyle adherence. PlexusDx compounded semaglutide starts at $149 per month with no flat per-compound pricing increases, making sustained treatment financially predictable. The Precision Peptide Genetic Test ($99 add-on after month one) helps identify whether you're a strong responder, moderate responder, or require combination therapy earlier in your journey.

How PlexusDx Semaglutide Supports Faster, Safer Progress

PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade purity and consistency at a lower cost than brand-name alternatives. Your dose can increase as needed to maintain weight loss momentum without ever increasing your monthly price—a financial model designed to keep treatment accessible whether you're taking 0.5 mg or your optimal higher dose.

PlexusDx serves all 50 states without requiring insurance, membership fees, or lengthy approval processes, delivering medication to your home within days of your consultation. HSA and FSA accounts cover PlexusDx treatment, providing additional cost savings. Pairing semaglutide with the optional Precision Peptide Genetic Test reveals whether your genes favor a faster response, helping your provider personalize your dosing timeline and predict when you might need to adjust your protocol.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I lose weight in the first week of starting semaglutide?

Most of your first-week changes are appetite suppression and reduced food cravings rather than scale weight loss; actual measurable weight loss typically begins by week two to three. The appetite reduction happens immediately because semaglutide begins signaling fullness to your brain right away, but visible weight loss requires a calorie deficit sustained over several days.

What does clinical research show about semaglutide weight loss timelines?

Clinical trials demonstrate average weight loss of approximately 15 percent of body weight over 68 weeks of continuous semaglutide use, with most loss occurring between weeks four and twenty-four. Patients typically lose one to two pounds per week during months two through six, then continue at a slower pace through month twelve and beyond.

How much does semaglutide cost with PlexusDx, and will my price increase if I need a higher dose?

PlexusDx compounded semaglutide injection starts at $149 per month with no flat per-compound pricing increases—your dose may go up as your treatment progresses, but your monthly cost remains flat. This pricing model ensures sustained access regardless of your final therapeutic dose.

What happens if I stop losing weight after a few months on semaglutide?

Weight loss plateaus are normal and reflect your body reaching a new equilibrium; often a gradual dose increase can restart progress, or lifestyle adjustments to diet and activity may help. PlexusDx providers can evaluate whether the Precision Peptide Genetic Test results suggest adding a second compound like tirzepatide (GLP-Squared Injection) to re-engage weight loss momentum.

Can the Precision Peptide Genetic Test predict how fast I'll lose weight?

PlexusDx's genetic test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite regulation and metabolic response, helping predict whether you're likely a fast responder, moderate responder, or may benefit from combination therapy. This insight allows your provider to set realistic timelines and optimize dosing from day one.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves